Aimns-To audit factors associated with the development of invasive cervical cancer. Methods-Twenty cases of invasive cervical cancer in one health district for 1991-93 were audited by multifactorial analysis. Results-The average age was 53 years with 20% (4/20) aged over 65 years. Of the patients, 45% (9/20) were identified by a cervical smear, with 40% (8/20) from the National Screening Programme (NSP) and 5% (1120) opportunistically; 30% (6120) 
development of invasive cervical cancer. Methods-Twenty cases of invasive cervical cancer in one health district for 1991-93 were audited by multifactorial analysis. Results-The average age was 53 years with 20% (4/20) aged over 65 years. Of the patients, 45% (9/20) were identified by a cervical smear, with 40% (8/20) from the National Screening Programme (NSP) and 5% (1120) opportunistically; 30% (6120) had not received a smear, 10% (2/20) being aged under 65 and 20% 65 or over. Those with no smear had all been hospital patients during the previous five years. No response to a smear invitation occurred in 5%. In 20%, there had been a true negative smear two to five years previously. Inappropriate laboratory diagnosis or inappropriate clinical management occurred in 300/o and 15% (3/20) , respectively. In 20%, two or more factors were present in the same patient. Conclusions-Why cervical cancer occurs after a true negative smear requires research and women aged over 65 with no smear must be targeted. Failsafe systems should incorporate inadequate smears and smear adequacy should be given priority in quality assurance (QA) and training. False negative reports must be minimised but accepted as an inherent part of the NSP and not an automatic indicator of poor laboratory performance. Com Factors associated with invasive cervical cancer fell into easily definable groups, with frequencies between 15 and 30%. Some of these groups were identical with those identified in the previous study of cervical cancer deaths.8 These included women over 65 years of age with no cytology record, true negative smears, laboratory errors, and inappropriate clinical management. However, in contrast to the previous study, there was a considerably smaller percentage of non-responders to a cervical smear invitation. There was also a fall in the percentage of women under 65 years of age with no cytology record, although the latter had been predicted as a consequence of the call programme.8 As in the previous study, there was no example of an abnormal smear being followed up inappropriately although, paradoxically, no district involved in the study had completed implementation of a laboratory based failsafe system. Also, in common with the previous study, 20% of patients had contributory factors belonging to at least two groups.
A new group identified by the present study included those women who presented symptomatically with no record of a previous cervical smear. For various reasons, all had been hospital patients at least once during the previous five years. However, an opportunistic smear test had not been undertaken on any occasion. Hospital in-and outpatients comprise a large female population. Accordingly, it is recommended that, at all hospital attendances, details of past medical history should routinely include cervical smear history. Then, if indicated, an opportunistic smear test could be advised. In addition, it is significant that all symptomatic presentations occurring in those under 65 years of age were due to postcoital bleeding, which must be highlighted as an absolute clinical indication for a cervical smear.
As in the previous study, the percentage of cases associated with a previous true negative smear is of concern and provides further support for a three rather than a five year recall interval. Furthermore, the contribution of poor smear taking to cytologically true negative smears requires further investigation.
Cervical smear inadequacy was associated with both clinical and laboratory problems in 20% of cases. In 5%, inadequate smears had taken up to two years to be repeated. Current national guidelines for failsafe mechanisms do not incorporate inadequate smears,'011 although this study indicates the clear necessity to do so. In 10% of cases misreported inadequate smears were the cause of a false negative laboratory report. Despite a national statement on smear adequacy,'2 there is still substantial interdistrict variation in the reporting frequency of inadequate smears. For these reasons, it is essential there is continuing education and research into the definition of smear adequacy, supported by both audit and inclusion of in-adequate smears in external quality assessment schemes. The latter would appear particularly pertinent as there have been suggestions that inadequate smears be removed from the national proficiency testing scheme.
Missed dyskaryosis was the cause of a false negative report in 10% of cases and all attempts must be made to minimise laboratory errors. However, there must be wider education that false negative reports, although unfortunate, are an inherent component of any screening programme. There is no national guidance as to what constitutes an acceptable laboratory false negative rate. Accordingly, there would appear to be an urgent requirement to set such standards for quality assurance, to which laboratory performance must conform.'314
In 40% of cases the previous clinical or laboratory information was obtained from either NHS hospitals and general practitioners outside the district or non-NHS sources. However, for audit into invasive cervical cancer to be successful, full access to all relevant clinical and laboratory information must be guaranteed. This may require a national directive to ensure its confidential release. Also, to be comprehensive, audit into invasive cervical cancer must include smear review.
A proposed essential component of the NSP is the multifactorial audit of both invasive cervical cancer and deaths from cervical cancer.8
The lessons learnt are the key to improving the effectiveness and quality of the NSP. 
